In general, eIF4A1 is much more abundant than eIF4A2 (8), which was also observed in the GEM models used in this study and in human breast cancers from the Clinical Proteomic Tumor Analysis Consortium (CPTAC) (Supplemental Figure 5, A and C) (44). The gene discussed is EIF4A2; the disease is breast cancer.